Nasopharyngeal cancer treatment cost in United Arab Emirates typically involves diagnostics like a biopsy running $650 to $1,700 and advanced radiation therapies such as Halcyon which ranges from $14,000 to $20,000. Total expenses depend on the cancer stage and the required combination of chemotherapy or targeted agents. Patients often save 30-50% compared to US medical costs in top healthcare hubs like Abu Dhabi and Dubai.
Typical Nasopharyngeal Cancer Treatment Costs in United Arab Emirates
Bookimed Expert Insight: Patients with advanced head and neck tumors benefit from multidisciplinary care at JCI-accredited facilities. Burjeel Medical City (BMC) offers quaternary care with ESMO-designated oncology services for complex cases. Dr. Sadir Alrawi, an American Board-certified surgical oncologist, provides expert management for nasopharyngeal malignancies. For those requiring systemic treatment, Dr. Mohanad Diab specializes in integrating immunotherapy and targeted therapy protocols. These centers use advanced PET-CT and SPECT-CT technologies to ensure precise staging and treatment monitoring.
| United Arab Emirates | Turkey | Austria | |
| Halcyon | ≈ $14,000 | ≈ $9,500 | ≈ $11,500 |
No hidden fees – just official clinic prices. Pay at the clinic for Nasopharyngeal cancer treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Nasopharyngeal cancer treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Nasopharyngeal cancer treatment journey.
Dr. Mohanad Diab is a clinical oncologist at Burjeel Hospital Abu Dhabi. He uses immunotherapy, targeted therapy, and chemotherapy to treat malignancies including brain, lung, and gastrointestinal cancers.
Dr. Sadir Alrawi is a board-certified surgical oncologist. He specializes in upper gastrointestinal, head and neck, minimally invasive, breast, and colorectal cancers. He also has expertise in heated chemoperfusion. Dr. Alrawi serves as the Director of Oncology Services at VPS Hospital system in the UAE and MENA region. He oversees several tertiary referral cancer centers.
Dr. Alrawi holds both American and British board certifications. He completed fellowships at Roswell Park Cancer Institute. He has previously led oncology divisions at Al Zahra Hospital, Tawam Hospital (a Johns Hopkins affiliate), and 21st Century Oncology in Florida. Dr. Alrawi has published widely and given many invited talks. He remains active in oncology research and education.